Physical review. ENeurosciencePeer-reviewed journal article
Boundary homogenization and numerical modeling of solute transport across the blood-brain barrier
Abstract
Effective clearance of amyloid-{beta} (A{beta}) from the brain is essential for preventing neurodegenerative diseases such as Alzheimers. A significant portion of this clearance occurs through the blood-brain barrier (BBB) via receptor-mediated transport. However, current models fail to capture the complex kinetics and spatial heterogeneity of receptors at the BBB. In this study, we derive a novel boundary condition that accounts for finite receptor kinetics, receptor density, and bidirectional transport across the BBB. Specifically, we develop a nonlinear homogenized boundary condition that ensures mass conservation and incorporates receptor-mediated Michaelis-Menten kinetics. We then implement this boundary condition in a cylindrical geometry representing a capillary surrounded by brain tissue. After verifying that the model matches an analytical steady state solution that we derive and that it yields realistic blood A{beta} concentrations, we explore how realistic variations in parameter values drive changes in both steady state A{beta} concentration and transient dynamics. Simulations and analytical results reveal that A{beta} concentrations in the brain are sensitive to receptor number ratios, while concentrations in the blood are primarily affected by the blood clearance rate. Additionally, we use the model to investigate A{beta} clearance during sequential sleep cycles and due to a pathological phenomenon, spreading depolarization. This work presents the first biophysically consistent boundary condition for A{beta} transport across the BBB, offering a powerful tool for studying brain waste clearance under both physiological and pathological conditions.
- Citations
- 1
- FWCI
- 0.36
- Field percentile
- top 37%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amyloid-beta peptides 40 and 42 employ distinct molecular pathways for cell entry and intracellular transit at the BBB endothelium
Zengtao Wang, Nidhi Sharda, … Karunya K. Kandimalla·bioRxiv·Nov 17, 2022
- Multivalent Targeting of Blood-Brain Barrier LRP1 for Neurovascular Recovery Therapy for Alzheimer s Disease
Junyang Chen, Pan Xiang, … Giuseppe Battaglia·bioRxiv·May 6, 2024
- Butyrate regulates the blood-brain barrier transport and intra-endothelial accumulation of Alzheimers disease Amyloid-beta peptides
Vaishnavi Veerareddy, Zengtao Wang, … Karunya K. Kandimalla·Molecular PharmaceuticsPeer-reviewed·May 21, 2026
- Quantitative Modelling of Amyloid-β Dynamics in Brain, CSF, and Plasma During Sleep and Wakefulness
Satyam Sangeet, Craig L. Phillips, … Svetlana Postnova·bioRxiv·Sep 14, 2026
- Numerical modeling of senile plaque development under conditions of limited diffusivity of amyloid-β monomers
A. V. Kuznetsov·bioRxiv·Jan 9, 2024
- The role of syndapin-2 mediated transcytosis across the blood-brain barrier on amyloid-beta accumulation in the brain
Diana M. Leite, Mohsen Seifi, … Giuseppe Battaglia·bioRxiv·Jul 12, 2020